Your browser doesn't support javascript.
loading
miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.
Wang, Fang; Lou, Jian-fang; Cao, Yan; Shi, Xin-hui; Wang, Peng; Xu, Jian; Xie, Er-fu; Xu, Ting; Sun, Rui-hong; Rao, Jian-yu; Huang, Pu-wen; Pan, Shi-yang; Wang, Hong.
Afiliación
  • Wang F; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Lou JF; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Cao Y; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Shi XH; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Wang P; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Xu J; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Xie EF; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Xu T; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Sun RH; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Rao JY; Department of Pathology and Anatomic Pathology, Ronald Reagan Medical Center of UCLA, Santa Monica, CA, USA.
  • Huang PW; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Pan SY; 1] Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [2] National Key Clinical Department of Laboratory Medicine, Nanjing Medical University, Nanjing, China.
  • Wang H; Department of Respiratory, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Exp Mol Med ; 47: e162, 2015 May 08.
Article en En | MEDLINE | ID: mdl-25952770

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cisplatino / Carcinoma de Pulmón de Células no Pequeñas / MicroARNs / Pulmón / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Mol Med Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2015 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cisplatino / Carcinoma de Pulmón de Células no Pequeñas / MicroARNs / Pulmón / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Mol Med Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2015 Tipo del documento: Article País de afiliación: China
...